Consumer Health
Over-the-counter (OTC) Products in the Middle East
Bayer’s extensive range of trusted personal health products leverages advanced science to enhance the daily well-being of billions worldwide. In the Middle East, Bayer has been a trusted name for over 130 years, offering a wide array of products that address prevalent health challenges through prevention, alleviation, and cure.
Through our trusted over-the-counter (OTC) products, we enhance the quality of life of the communities we serve by providing evidence-based solutions and upholding the highest standards of quality. Every day, we apply our knowledge and expertise to develop products that help people lead healthier, better lives.
As part of its commitment to improving patient outcomes living with cardiovascular diseases, Bayer partnered with the Egyptian Ministry of Health and Population (MoHP) to sponsor the "Albak Amanah" (Your Heart is Precious) initiative for the early detection of heart diseases in Egypt. This effort, which will run for a minimum of three years under the presidential “100 million Health” initiative, focuses on heart diseases common in elderly patients. Alongside public awareness efforts, "Albak Amanah" aims to train 5000 healthcare professionals across 401 primary healthcare facilities in 21 governorates through an extensive educational program aimed at enhancing their expertise in cardiovascular care.
In May 2024, Bayer and Huma Therapeutics expanded their partnership by launching an innovative digital heart health risk assessment tool in Saudi Arabia, a step that aligns with Saudi Arabia's Vision 2030 healthcare transformation strategy. The tool offers a non-invasive method to rapidly evaluate and predict cardiovascular disease risk. This initiative underscores Bayer's commitment to leveraging digital health solutions for preventive care in the region, while also supporting Saudi Arabia’s broader goals of reducing the burden of cardiovascular diseases through early detection and improved access to healthcare.